SignatureFD’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Other funds holding DNA
SignatureFD's DNA Position: Q3 2026 in Review
SignatureFD reduced its Ginkgo Bioworks (DNA) stake by 50% in Q3 2026, selling an estimated $1.79K and leaving 222 shares worth $2.85K. The position accounts for ﹤0.01% of the portfolio, ranked #3098.
SignatureFD first reported a position in DNA in Q3 2022 and has held it in 14 quarters since. The position peaked at $12.6K in Q3 2023. 180 funds tracked by Wall St. Rank hold DNA as of Q3 2026.
- SignatureFD held 222 shares of Ginkgo Bioworks worth $2.85K as of Q3 2026.
- SignatureFD sold 220 Ginkgo Bioworks shares in Q3 2026, an estimated $1.79K.
- Ginkgo Bioworks made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #3098 holding.
- SignatureFD first reported a position in Ginkgo Bioworks in Q3 2022 and has held it in 14 quarters since.
- SignatureFD's Ginkgo Bioworks position peaked at $12.6K in Q3 2023.
- 180 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.
Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.